Universitätsklinikum Bonn, Venusberg-Campus 1
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Holderried, Tobias
IDUNN, NCT04629833 / 2019-001462-15: Treatment of Steroid-Refractory Acute Graft-versus-host Disease with Mesenchymal Stromal Cells Versus Best Available Therapy

Recruiting
3
210
Europe
MC0518, BAT
medac GmbH
Steroid-refractory Acute Graft-versus-host Disease
08/27
08/30
AlloRelapseMM, NCT05675319: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Recruiting
3
482
Europe
Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD), elotuzumab/lenalidomide/dexamethasone (ERD), daratumumab/bortezomib/dexamethasone (DVD), daratumumab/lenalidomide/dexamethasone (DRD), ixazomib/lenalidomide/dexamethasone (IRD), pomalidomide/bortezomib/dexamethasone (PVD), carfilzomib/daratumumab/dexamethasone (KDD), Autologous Stem Cells, daratumumab/pomalidomide/dexamethasone (DPD), isatuximab/carfilzomib/dexamethasone (Isa-KD), selinexor/bortezomib/dexamethasone (SVD)
Universitätsklinikum Hamburg-Eppendorf, Gemeinsamer Bundesausschuss (G-BA), Staburo GmbH
Multiple Myeloma
03/28
03/33
HAMLET, NCT03275636 / 2015-005399-12: Haploidentical Donor vs mMUD in Hematological Malignancies

Completed
2/3
98
Europe
Peripheral blood stem cells, PBSC
DKMS gemeinnützige GmbH
AML, ALL, MDS
04/24
04/24
PHOEBUS, NCT05762211: Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications ( Trial)

Recruiting
2
387
Europe
Pooled allogeneic fecal microbiotherapy, MaaT033, Placebo
MaaT Pharma
Transplant Complication
10/26
02/27
ACTengine, NCT03686124 / 2019-002370-31: ® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Checkmark ORR data from ACTengine trial for solid tumors
Nov 2021 - Nov 2021: ORR data from ACTengine trial for solid tumors
Checkmark Initial data from dose expansion trial for r/r solid tumors
Mar 2021 - Mar 2021: Initial data from dose expansion trial for r/r solid tumors
Recruiting
1
476
Europe, US
IMA203 Product, IMA203 product- flat dose, IMA203CD8 Product, nivolumab (Opdivo®), Opdivo®, IMADetect®
Immatics US, Inc., Immatics US Inc
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
12/28
12/28
NCT05414162: Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Recruiting
N/A
60
Europe
Cardiac MRI
University Hospital, Bonn
DLBCL, Multiple Myeloma, Cytokine Release Syndrome, Myocarditis, CAR T-cell Therapy, ALL, PCBCL, Follicular Lymphoma, MCL
05/24
12/25

Download Options